With a revenue increase of 55.99% in the fourth quarter 2025, year on year to cumulative value of $7 million, Immuron Limited's revenue per employee grew on a trailing twelve months basis to $ 845,637. The productivity of Immuron Limited's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 249 other companies have achieved higher revenue per employee. While Immuron Limited's total ranking has deteriorated compared to the previous quarter from 0 to 2037. Immuron Limited has 8 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IMRN Revenue per Employee	(Jun 30 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Jun 30 2024) IV. Quarter
Y / Y Revenue Change	55.99 %	-	-	-	192.95 %
Sales per Employee (TTM) $	845,637	542,100	542,100	542,100	542,100
IMRN's Total Ranking	# 2037	# 0	#	#	#
Seq. Revenue Change	-	-	-	-	-

IMRN Company Profile >> Back to IMRN Efficiency Comparisons >> Compare IMRN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 128
Healthcare Sector	# 250
Overall Market	# 2037

Revenue per Employee Statistics
High	Average	Low
$ 563,758	$ 231,868	$ 12,148
(Jun 30 2025)		(Jun 30 2021)

Financial Statements
Immuron Limited's Revenue MRQ	$ 7 Millions	Visit IMRN's Income Statement
Immuron Limited's Revenues TTM	$ 7 Millions	Visit IMRN's aggregate revenue growth
What are IMRN's Sales?		Visit IMRN's Sales by Segment

Other Ratios
Immuron Limited's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
IMRN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for IMRN's Competitors
Revenue per Employee for IMRN's Suppliers
Revenue per Employee for IMRN's Customers

You may also want to know
IMRN's Sales Growth Rates	IMRN's Pe Price to earnings ratio	IMRN's Receivables Turnover Ratio	IMRN's Stock Quote
IMRN's Net Income Growth Rates	IMRN's Ps Price to Sales ratio	IMRN's Sales per Employee	IMRN's Asset Turnover Ratio
IMRN's Net Margin	IMRN's Pb Price to Book ratio	IMRN's Financial Strength Ratios	IMRN's Dividend Payout Ratio

Date modified: 2026-07-07T11:25:07+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2025, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2025	Number of Employees Jun 30 2025
Bristol myers Squibb Company	1,467,815.38	$ 47,704.000 Million	32,500
Progyny Inc	1,450,285.05	$ 1,241.444 Million	856
Kiniksa Pharmaceuticals International Plc	1,446,262.30	$ 529.332 Million	366
Novavax inc	1,440,210.95	$ 1,078.718 Million	749
Avadel Pharmaceuticals Plc	1,436,136.36	$ 221.165 Million	154
Jazz Pharmaceuticals Plc	1,414,081.31	$ 4,086.695 Million	2,890
Semler Scientific inc	1,386,387.10	$ 42.978 Million	31
Biogen Inc	1,332,933.33	$ 9,997.000 Million	7,500
Eton Pharmaceuticals Inc	1,330,977.27	$ 58.563 Million	44
Puma Biotechnology Inc	1,329,955.31	$ 238.062 Million	179
Scilex Holding Company	1,301,058.82	$ 44.236 Million	34
Biocryst Pharmaceuticals Inc	1,281,622.99	$ 557.506 Million	435
Acadia Pharmaceuticals Inc	1,276,799.50	$ 1,018.886 Million	798
Lantheus Holdings Inc	1,274,419.11	$ 1,520.382 Million	1,193
Agenus Inc	1,255,629.63	$ 101.706 Million	81
Neurocrine Biosciences Inc	1,254,950.00	$ 2,509.900 Million	2,000
Vaxart Inc	1,241,907.69	$ 80.724 Million	65
Xenetic Biosciences Inc	1,223,110.50	$ 2.446 Million	2
Krystal Biotech Inc	1,217,647.46	$ 359.206 Million	295
Nektar Therapeutics	1,189,428.57	$ 74.934 Million	63
Monte Rosa Therapeutics Inc	1,186,573.33	$ 177.986 Million	150
Anaptysbio Inc	1,184,269.23	$ 123.164 Million	104
Stoke Therapeutics Inc	1,175,847.06	$ 199.894 Million	170
Heron Therapeutics Inc	1,161,671.88	$ 148.694 Million	128
Mirum Pharmaceuticals Inc	1,153,658.60	$ 429.161 Million	372
Dynavax Technologies Corporation	1,150,061.82	$ 316.267 Million	275
Tg Therapeutics Inc	1,138,015.04	$ 454.068 Million	399
Amicus Therapeutics inc	1,115,393.35	$ 569.966 Million	511
Arcturus Therapeutics Holdings Inc	1,100,198.20	$ 122.122 Million	111
Marker Therapeutics inc	1,077,614.20	$ 5.388 Million	5

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.